Articles related to MEDICARE

“Patients hospitalized for HFrEF in US clinical practice are at very high risk of poor clinical outcomes, even when prescribed quadruple medical therapy.” — Dr. Stephen J. Greene, Duke Clinical Research Institute

“Patients and doctors [lack] enough research to inform medical guidelines and many patients are using these products without talking to their doctor about them.” —Senior White House official

Medicare patients switch plans based on care access, not costs—knowledge that helps NPs/PAs guide better insurance decisions. Understanding these patterns strengthens patient advocacy and care continuity efforts.

Medicare reimbursement for RPM remains lowest in rural areas where chronic disease prevalence exceeds national averages and provider access presents significant challenges.

The median post-rebate spending per beneficiary was higher for the low-added-benefit drugs ($70,524) than for the high-added-benefit drugs ($61,277).

“Congressional action is required to prevent the severe limitations on telehealth that existed before the COVID-19 pandemic from being restored,” said American Medical Association president Bruce A. Scott, MD.